| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/26/2006 | US20060019977 Spiroheterocyclic derivative compounds and drugs comprising the compound as the active ingredient |
| 01/26/2006 | US20060019945 Granzyme b inhibitors |
| 01/26/2006 | US20060019897 Anti-angiogenic polypeptides |
| 01/26/2006 | US20060019336 Factor VII or VIIa - like molecules |
| 01/26/2006 | US20060019294 Tyrosine kinase substrate (Tks) proteins |
| 01/26/2006 | US20060018892 nucleic acid molecule comprising nucleotide sequences, that code fro single chain proteins which are serine protease inhibitors, used for prophylaxis of emphysema, cirrhosis, hepatitis, blood disorders, tumors and tumor metastasis |
| 01/26/2006 | CA2573674A1 Muscarinic antagonists with parp and sir modulating activity as agents for inflammatory diseases |
| 01/26/2006 | CA2573393A1 Combinations of statins with bronchodilators |
| 01/26/2006 | CA2572047A1 Octahydropyrrolo[2,3,c]pyridine derivatives and pharmaceutical use thereof |
| 01/26/2006 | CA2570817A1 Azaindoles modulating c-kit activity and uses therefor |
| 01/26/2006 | CA2570433A1 Medicaments for inhalation comprising pde iv inhibitors and enantiomerically pure glycopyrrolate salts |
| 01/26/2006 | CA2568534A1 Vegf inhibitors for the treatment of malignant pleural effusion |
| 01/26/2006 | CA2553065A1 New pharmaceutical compositions based on fluorenecarboxyclic acid esters and soluble tnf receptor fusion proteins |
| 01/25/2006 | EP1619194A2 Triazaspiro[5.5]undecane derivatives and pharmaceutical composition comprising the same as active ingredient |
| 01/25/2006 | EP1619193A1 Spiropiperidine compound and medicinal use thereof |
| 01/25/2006 | EP1618189A2 Rnai agents for anti-sars coronavirus therapy |
| 01/25/2006 | EP1513826B1 New indolylpiperidine derivatives as potent antihistaminic and antiallergic agents |
| 01/25/2006 | EP1235825B1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 01/25/2006 | CN1726213A Imidazoquinoline derivatives as adenosine A3 receptor ligands |
| 01/25/2006 | CN1726201A Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 01/25/2006 | CN1726036A Composition comprising pseudoephedrine and domperidone for preventing snoring |
| 01/25/2006 | CN1726023A Pregabalin and derivatives thereof for the treatment of fibromyalgia and other related disorders |
| 01/25/2006 | CN1726022A Pregabalin derivatives for the treatment of fibromyalgia and other disorders and its derivitive |
| 01/25/2006 | CN1726021A Alpha2delta ligands for the treatment of sexual dysfunction |
| 01/25/2006 | CN1726015A Alpha2delta ligands for different pharmaceutical uses |
| 01/25/2006 | CN1724069A Method for preparing vaccine of fowl infectious coryza |
| 01/25/2006 | CN1724025A Method for controlling quality of injection liquid or powder of |
| 01/25/2006 | CN1724023A Method for preparing Qingkailing |
| 01/25/2006 | CN1724019A Medicine for relieving-cough and asthma |
| 01/25/2006 | CN1724007A Medicine contg. zinc, honeysuckle, Radix scutellariae and forsynthia fruit |
| 01/25/2006 | CN1724006A Method for producing granular medicine contg. honeysuckle, Radix scutellariae and foysythia fruit |
| 01/25/2006 | CN1724001A Traditional Chinese medicinal prepn. for treating respiratory tract infection, and its prepn. method |
| 01/25/2006 | CN1723985A Traditional Chinese medicine for treating mumps |
| 01/25/2006 | CN1723981A Novel use of extractive of Momordica grosvenori as adjuvant drug for preparing medicine |
| 01/25/2006 | CN1723967A Injection of Herba Andrographitis, and its prepn. method |
| 01/25/2006 | CN1723964A Medicine for treating cough and chronic bronchitis |
| 01/25/2006 | CN1723958A Method for extracting spore oil from exosporium-broken spore of glossy ganoderma |
| 01/25/2006 | CN1723955A Extractive of rhizome belamcandae, prepn. method and use thereof |
| 01/25/2006 | CN1723920A Masa Medicata Fermentate health-care prepn., and its prepn. method |
| 01/25/2006 | CN1723910A Injectable azithromycin freeze-dried powder, and its prepn. method |
| 01/25/2006 | CN1723905A Cefdinir oral disintegration tablet, and its prepn. method |
| 01/25/2006 | CN1238367C Isolated nucleic acid molecules which encode T cell inducible factors (TIF), proteins encoded, and uses thereof |
| 01/25/2006 | CN1238054C Biotechnological formulation for suppressing and killing helicobacter pylori, its preparation and its uses |
| 01/25/2006 | CN1238037C Medicine for treating pneumonia and SARS |
| 01/25/2006 | CN1238031C Oral liquid for treating virus cold and throat disease and its preparation technology |
| 01/25/2006 | CN1238026C Chinese powder medicine for eradicating bronchitis |
| 01/25/2006 | CN1238006C Medicament for treating pulmonary neoplasm, asthma and trachitis and method for making same |
| 01/25/2006 | CN1237999C Medicine for treating wind-warm lung-heat illness of children and preparation method thereof |
| 01/25/2006 | CN1237998C Effervescence tablet for treating children's cough and asthma |
| 01/25/2006 | CN1237989C Drug for upper respiratory tract infection |
| 01/25/2006 | CN1237973C Chronic bronchitis treating traditional Chinese medicine |
| 01/25/2006 | CN1237970C Inhalant containing tiotropium salt solution |
| 01/25/2006 | CN1237965C Oral disintegrating tablet of bambuterol hydrochloride and its preparation method |
| 01/24/2006 | US6989395 TNF inhibitors |
| 01/24/2006 | US6989393 Ccr5 modulators benzimidazoles or benzotriazoles |
| 01/24/2006 | US6989385 Pyrazole compounds useful as protein kinase inhibitors |
| 01/24/2006 | US6989372 medicaments intended to increase the intracellular and/or extracellular level of glutathione (GSH); for example, N-(N-Acetyl-L-cysteinyl)-S-acetylcysteamine; hiv treatment |
| 01/24/2006 | US6989260 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders |
| 01/24/2006 | US6989156 Forming a free- standing powder comprising at least one antimicrobial metal with atomic disorder; and injecting the free-standing powder in therapeutically effective amounts to the tissue which is to be treated |
| 01/24/2006 | US6989155 Particles comprising amino acid such as leucine and optionally with drug mixtures formed by aerosol condensation or spray drying, for use as inhalants; antiasthmatics |
| 01/24/2006 | US6989145 Chimeric antibody for use in the diagnosis and treatment of blood cancer and immune defects |
| 01/24/2006 | CA2386828C Novel pseudoerythromycin derivatives |
| 01/24/2006 | CA2292984C Ccr5 modulators |
| 01/24/2006 | CA2255447C Percutaneous absorption type preparation |
| 01/24/2006 | CA2187525C Quinolone derivative for treatment of urinary incontinence |
| 01/19/2006 | WO2006006740A1 3-aminobenamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 01/19/2006 | WO2005117890A3 Thienopyrimidines and thiazolopyrimidines for use in medicine |
| 01/19/2006 | US20060014963 2-Oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists |
| 01/19/2006 | US20060014948 e.g 1-[3,5-bis(trifluoromethyl)benzoyl]-2-[3-[(2-methoxyethoxy)-methoxy]-4-methylbenzyl]-4-[2-[(3R)-3-methoxymethyl-morpholino]ethyl]piperazine; treating or preventing Tachykinin-mediated diseases in humans or animals |
| 01/19/2006 | US20060014835 Therapeutic agent for chronic obstructive pulmonary disease |
| 01/19/2006 | US20060014830 2-amino-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate and 2-(methylamino)-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate; fatty acid amide (FAAH) hyrdrolase inhibitors; analgesics; neuropathic pain;psychological disorders; anticarcinogenic agents; AIDS |
| 01/19/2006 | US20060014792 Heterocyclo inhibitors of potassium channel function |
| 01/19/2006 | US20060014787 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 01/19/2006 | US20060014780 Nicotinamide derivatives useful as PDE4 inhibitors |
| 01/19/2006 | US20060014725 6-(1-benzyl-3-pentyl-1H-indol-2-yl)-1-bromo-2-naphthyl 1H-tetraazol-5-ylmethyl ether; useful in treating stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 01/19/2006 | US20060014701 Novel amide derivatives as growth hormone secretagogues |
| 01/19/2006 | US20060014180 Human phosphatase RET31, and variants thereof |
| 01/19/2006 | US20060013897 Compositions for cancer therapy saponins or sapogenins |
| 01/19/2006 | US20060013869 Electrospun amorphous pharmaceutical compositions |
| 01/19/2006 | US20060013777 Novel treatment for cough |
| 01/19/2006 | US20060013775 Use of ppar activators for the treatment of pulmonary fibrosis |
| 01/19/2006 | DE202005018338U1 Pharmaceutical composition, in lozenge form, useful e.g. for treating dry cough, hoarseness and inflammatory diseases of mouth and throat, comprises Lichen islandicus and/or Mentha piperita, carrier, diluents, additives and sweeteners |
| 01/19/2006 | DE102004063363A1 Composition for treatment and prevention of bronchial disease or allergy and for strengthening immune system, contains capsaicin or its derivatives |
| 01/18/2006 | EP1617216A1 Novel method of screening |
| 01/18/2006 | EP1616869A1 Substituted porphyrins and their therapeutic use |
| 01/18/2006 | EP1616862A1 Nitrogenous heterocyclic compound and use thereof |
| 01/18/2006 | EP1616861A2 A process for the preparation of keto compounds |
| 01/18/2006 | EP1616575A1 Method for treating inflammation |
| 01/18/2006 | EP1616573A2 Adjuvants for use in vaccines |
| 01/18/2006 | EP1616569A1 Medicinal composition |
| 01/18/2006 | EP1616567A1 Medicaments for inhalation comprising PDE IV inhibitors and glycopyrrolate salts |
| 01/18/2006 | EP1616563A2 Perivascular administration of anti-angiogenic factors for treating or preventing vascular diseases |
| 01/18/2006 | EP1615912A1 4-, 6- o 7-hydroxyindoles having n-oxide groups and the use thereof as therapeutic agents |
| 01/18/2006 | EP1615898A1 2-aminopyrimidine derivatives and their medical use |
| 01/18/2006 | EP1615887A1 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 01/18/2006 | EP1615881A2 Diarylmethyl and related compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 01/18/2006 | EP1615652A2 Treatment of severe acute respiratory syndrome (sars) |
| 01/18/2006 | EP1615634A1 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 01/18/2006 | EP1487968A4 Methods of inducing differentiation of stem cells into a specific cell lineage |
| 01/18/2006 | EP1470138B1 Mmp inhibitors |